Literature DB >> 21256671

Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use.

Axel Heidenreich.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21256671     DOI： 10.1016/j.eururo.2011.01.013

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  19 in total

1.  Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice.

Authors:  Andrea Billing; Alexander Buchner; Christian Stief; Alexander Roosen
Journal:  World J Urol       Date:  2014-11-29       Impact factor: 4.226

2.  Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.

Authors:  Andrew B Rosenkrantz; Luke A Ginocchio; Daniel Cornfeld; Adam T Froemming; Rajan T Gupta; Baris Turkbey; Antonio C Westphalen; James S Babb; Daniel J Margolis
Journal:  Radiology       Date:  2016-04-01       Impact factor: 11.105

3.  Value of three-dimensional T2-weighted turbo spin-echo imaging with tissue-specific variable refocusing flip angle for 3-T magnetic resonance imaging of prostate cancer: comparison with conventional two- and three-dimensional T2-weighted turbo spin-echo imaging.

Authors:  Utaru Tanaka; Yoshiko Ueno; Yukiko Morinaga; Hideaki Miyake; Katsusuke Kyotani; Yu Ueda; Kazuhiro Kitajima; Keitaro Sofue; Yuko Suenaga; Kazuro Sugimura; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2017-10-05       Impact factor: 2.374

4.  Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI?

Authors:  Olivier Rouvière; Matthieu Papillard; Nicolas Girouin; Romain Boutier; Muriel Rabilloud; Benjamin Riche; Florence Mège-Lechevallier; Marc Colombel; Albert Gelet
Journal:  Eur Radiol       Date:  2012-01-07       Impact factor: 5.315

5.  Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology.

Authors:  Lars Boesen; Elizaveta Chabanova; Vibeke Løgager; Ingegerd Balslev; Kari Mikines; Henrik S Thomsen
Journal:  Eur Radiol       Date:  2014-12-11       Impact factor: 5.315

6.  Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.

Authors:  Thomas J Pugh; Steven J Frank; Mary Achim; Deborah A Kuban; Andrew K Lee; Karen E Hoffman; Sean E McGuire; David A Swanson; Rajat Kudchadker; John W Davis
Journal:  Brachytherapy       Date:  2012-06-05       Impact factor: 2.362

7.  The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Authors:  Berrend G Muller; Jurgen J Fütterer; Rajan T Gupta; Aaron Katz; Alexander Kirkham; John Kurhanewicz; Judd W Moul; Peter A Pinto; Ardeshir R Rastinehad; Cary Robertson; Jean de la Rosette; Rafael Sanchez-Salas; J Stephen Jones; Osamu Ukimura; Sadhna Verma; Hessel Wijkstra; Michael Marberger
Journal:  BJU Int       Date:  2013-11-13       Impact factor: 5.588

8.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 9.  Prostate focused ultrasound focal therapy--imaging for the future.

Authors:  Olivier Rouvière; Albert Gelet; Sébastien Crouzet; Jean-Yves Chapelon
Journal:  Nat Rev Clin Oncol       Date:  2012-08-21       Impact factor: 66.675

10.  Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use.

Authors:  Jelle O Barentsz; Jeffrey C Weinreb; Sadhna Verma; Harriet C Thoeny; Clare M Tempany; Faina Shtern; Anwar R Padhani; Daniel Margolis; Katarzyna J Macura; Masoom A Haider; Francois Cornud; Peter L Choyke
Journal:  Eur Urol       Date:  2015-09-08       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.